UPAR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN RECURRENT GLIOBLASTOMA

Glioblastoma (GBM) is the common malignant brain tumor in adults, accounting for approximately 15% of all CNS tumors, and 48.6% of malignant brain tumors, with a median survival of approximately 15 months, and minimal clinical progress having been made in the past two decades. GBM is characterized b...

Descripción completa

Detalles Bibliográficos
Autores principales: Maich, William, Shaikh, Vaseem, Puri, Anish, Anand, Alisha, Rosotti, Martin, Savage, Neil, Chokshi, Chirayu, Suk, Yujin, Gwynne, Will, Seyfrid, Mathieu, Venugopal, Chitra, Henry, Kevin, Singh, Sheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337559/
http://dx.doi.org/10.1093/noajnl/vdad071.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337559/
http://dx.doi.org/10.1093/noajnl/vdad071.041

Ejemplares similares